APA Alıntı

Babu, G., Saldanha, S. C., Kuntegowdanahalli Chinnagiriyappa, L., Jacob, L. A., Mallekavu, S. B., Dasappa, L., . . . Arroju, V. (2016). The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India. Chemother Res Pract.

Chicago Stili Alıntı

Babu, Govind, et al. "The Efficacy, Safety, and Cost Benefit of Olanzapine Versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study From South India." Chemother Res Pract 2016.

MLA Alıntı

Babu, Govind, et al. "The Efficacy, Safety, and Cost Benefit of Olanzapine Versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study From South India." Chemother Res Pract 2016.